Development of C-SMART: Cognitive Strategies, Mindfulness, and Rehabilitation Therapy for Patients With Glioma (C-SMART)
Glioma, Mixed, Mild Neurocognitive Disorder
About this trial
This is an interventional supportive care trial for Glioma, Mixed focused on measuring Mindfulness, Cognitive rehabilitation
Eligibility Criteria
Inclusion Criteria: Adults with a glioma diagnosis confirmed by histology At least one domain of neurocognitive function ≥ 1.5 SD below estimate premorbid functioning Karnofsky' Performance Status (KPS) score ≥ 80 ≥ 1 month out of radiation therapy Ability to read, speak, and understand English Exclusion Criteria: Inability to attend virtual sessions Inability to understand and provide informed consent Presence of clinically significant insomnia
Sites / Locations
- Virginia Commonwealth UniversityRecruiting
Arms of the Study
Arm 1
Experimental
C-SMART
C-SMART intervention will be provided via telehealth. Participants will complete in-person neurocognitive testing (baseline, post-intervention) as well as surveys (baseline, post-session, post-intervention) via secure email link. Exit interviews will be conducted by Zoom.